NSEResignation1d ago · 31 Oct 2026, 02:32 pm

Resignation

Fortis Healthcare Limited · FORTIS

✦ AI SummaryMgmt Change

Fortis Healthcare Limited has informed the Exchange regarding the resignation of Dr. Ritu Garg as Chief Growth & Innovation Officer, effective October 31, 2026, due to other commitments and responsibilities.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fortis Healthcare Limited has informed the Exchange regarding Resignation of Dr. Ritu Garg as Other of the company w.e.f. October 31, 2026.

Attachments (1)

📄

FORTIS_31102026143202_finalfinal.pdf

pdf

Download →
View document text
» Fortis Healthcare Limited ** Fo'fis Tower-A, Unitech Business Park, Block-F, South City 1, Sector — 41, Gurgaon, Haryana — 122 001 (India) Tel 10124 492 1033 Fax 10124 492 1041 Emergency : 105010 Email : secretarial@fortishealthcare.com Website : www.fortishealthcare.com October 31, 2026 FHL/SEC/2026-27 The National Stock Exchange of India Ltd. BSE Limited Scrip Symbol: FORTIS Scrip Code:532843 Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Intimation on resignation ofa Senior Management Personnel Dear Madam / Sir, Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with SEBI Master Circular dated January 30, 2026, we would like to inform you that Dr. Ritu Garg, Chief Growth & Innovation Officer of the Company, one of the Senior Management Personnel (“SMP”) of the Company has tendered her resignation with effect from October 31, 2026 (from close of business hours) due to other commitments and responsibilities The detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 is enclosed as Annexure-A. Further, the copy of her resignation letter is also enclosed as Annexure- B. The aforesaid intimation shall be made available on the Company’s website at www.fortishealthcare.com This is for your information and record. Thanking you, Yours Sincerely, For Fortis Healthcare Limited Satyendra Chauhan Company Secretary & Compliance Officer M. No. — A14783 Encl.: as above FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase — VI, Mohali - 160062 Tel : 01724692222, Fax: 0172-5096221, CIN : L85110PB1996PLC045933 $2 Fortis Fortis Healthcare Limited Tower-A, Unitech Business Park, Block-F, South City 1, Sector — 41, Gurgaon, Haryana — 122 001 (India) Tel 10124 492 1033 Fax 10124 492 1041 Emergency : 105010 Email : secretarial@fortishealthcare.com Website : www.fortishealthcare.com Annexure A Disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015 Particulars Description Reason for change viz. appeintment, DDr. Ritu Garg, Chief Growth & Innovation Officer of] re-appointment.—resignation, removaly the Company, one of the Senior Managemen deatrorothorwises [Personnel (“SMP”) of the Company has tendered her resignation with effect from October 31, 2026 (from| close of business hours) due to other commitments and| responsibilities. Date of appeintment—re- ith effect from October 31, 2026 (from close of appointment/ cessation (as [business hours). applicable) & term of appointment. Brief profile (in case of NA appointment). Disclosure of relationships betweenNA directors (in case of appointment of director). FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase — VI, Mohali - 160062 Tel : 01724692222, Fax: 0172-5096221, CIN : L85110PB1996PLC045933 October 31, 2026 Fortis Healthcare Limited Fortis Hospital, Sector 62, Phase-VIII, Mohali - 160062, Punjab Sub: Resignation from the position of Chief Growth & Innovation Officer of the Company 1 hereby tender my resignation from the position of Chief Growth & Innovation Officer of the Company, with effect from the closure of business hours on Saturday, October 31, 2026 in order to pursue a professional opportunity outside the organization. [ take this opportunity to convey my gratitude to the Board of Directors and Management team of the Company for co-operation, trust and support extended to me throughout during my tenure. I wish the Company every success with its future plans and ambitions. Thanking you Yours Truly Dr. Ritu Garg Chief Growth & Innovation Officer Address- D 8, Surbhi Apartment, Sector 43, Next to Gold Souk, Gurgaon